SCHEMBL6828197

SCHEMBL6828197

CCOC(=O)c1[nH]c(C)c(-c2ccc(C(=O)N(C)c3cccc(C(C)C)c3)cc2)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.41
HSD17B2 P37059 4/20 0.41
KMT2A Q03164 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 3/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6828205 0.77 KMT2A (0.50) KMT2ACYP1A2CYP2C9CYP2C19GAA
SCHEMBL6825127 0.77 KMT2A (0.50) KMT2ACYP1A2CYP2C9CYP2C19GAA
SCHEMBL6828520 0.76 KMT2A (0.49) KMT2ACYP1A2CYP2C9CYP2C19GAA
SCHEMBL6828537 0.75 MAPT (0.58) KMT2AGAAMEN1RAB9AALDH1A1
SCHEMBL6828196 0.75 LMNA (0.53) KMT2ACYP1A2GAAMEN1RAB9A
SCHEMBL6825311 0.74 RAB9A (0.69) KMT2ACYP1A2CYP2C9CYP2C19GAA
SCHEMBL6825638 0.74 MAPT (0.47) KMT2AMEN1RAB9AALDH1A1HTT
SCHEMBL5396489 0.73 KMT2A (0.58) KMT2ACYP1A2CYP2C9CYP2C19MEN1
SCHEMBL6828515 0.72 MAPT (0.52) KMT2AGAAMEN1RAB9AALDH1A1
SCHEMBL6825634 0.71 ALDH1A1 (0.44) KMT2ACYP1A2CYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138269-A1 Substituted pyrroles as kinase inhibitors SUGEN, INC. 2004-07-15 US claimed
US-20040138269-A1 Substituted pyrroles as kinase inhibitors SUGEN, INC. 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138269-A1 Substituted pyrroles as kinase inhibitors PHKG1, PHKG2, MAP3K20 HSD17B1 1921/4885HSD17B2 2269/4885KMT2A 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.